Subscribe free

HPB & Spleen ·

Robotic liver resection is safe and feasible for huge hepatocellular carcinoma in a single-surgeon study

Robotic liver resection for huge hepatocellular carcinoma (HCC) is feasible, with comparable perioperative outcomes to regular HCC cases. A single-surgeon study of 337 patients showed no significant differences in major perioperative indicators between regular and huge HCC groups. Effective perioperative risk management suggests potential benefits for subsequent minimally invasive surgeries.

Journal Article by Wu S, Boyuan L (…) Hu M et 3 al. in Int J Med Robot

© 2024 John Wiley & Sons Ltd.

read the whole article in Int J Med Robot

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Surg Endosc6 Nov 2026

A new cut for robotic liver surgery

A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.

All papers in HPB & Spleen →